Pancreatic Cancer Research

ResearcherOU Health Stephenson Cancer CenterActive in the last 2 years

Susanna Varkey Ulahannan

Matched on ORCID iD 0000-0002-7234-2283; OpenAlex author ID A5045993166. Sources: ClinicalTrials.gov.

Their work

Papers
8
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
54
Papers, trials and grants by year

2024: 2 papers · 2025: 3 papers · 2026: 3 papers, 1 trial

Papers 8

  1. Peptide-Based Probe Targeting Angiotensin Type‑1 Receptor Identifies Pancreatic Ductal Adenocarcinoma Using Multispectral Optoacoustic Tomography. Co-author DOI 10.1021/cbmi.5c00128↗
  2. Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial. Co-author DOI 10.1038/s41591-026-04283-z↗
  3. KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-1984↗
  4. SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multic… Co-author DOI 10.1097/sla.0000000000006966↗
  5. Brief Report: A Phase 1 Study Evaluating Extracorporeal Blood Purification to Remove Circulating Tumor Cells in Patients with Metastatic Pancreatic Adenocarcin… Co-author DOI 10.1101/2025.04.29.25326588↗
  6. Extracorporeal blood filtration leading to tumor growth arrest and reduced analgesic requirements in Stage IV poorly differentiated pancreatic adenocarcinoma: … Co-author DOI 10.18632/oncotarget.28756↗
  7. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Co-author DOI 10.1038/s41556-024-01372-4↗
  8. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 … Co-author DOI 10.1038/s41556-024-01417-8↗

Trials 1

  1. Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer Principal investigator NCT07829185↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lakhmir S. Chawla · 2 shared papers, 2025 · strength 0.62
  2. Barish H. Edil · 3 shared papers, 2024–2026 · strength 0.58
  3. Kamiya Mehla · 3 shared papers, 2024–2026 · strength 0.50
  4. Tuo Hu · 3 shared papers, 2024–2026 · strength 0.50
  5. Chunbo He · 3 shared papers, 2024–2026 · strength 0.50
  6. Ravi Kumar Thakur · 3 shared papers, 2024–2026 · strength 0.50
  7. Pankaj Kumar Singh · 3 shared papers, 2024–2026 · strength 0.50
  8. Surendra Kumar Shukla · 3 shared papers, 2024–2026 · strength 0.50
  9. Rohit Singh · 1 shared paper, 2026 · strength 0.30
  10. Happy Agarwal · 1 shared paper, 2026 · strength 0.30
  11. Lacey R. McNally · 1 shared paper, 2026 · strength 0.30
  12. Rosa F. Hwang · 2 shared papers, 2024 · strength 0.28
  13. Ajay Jain · 2 shared papers, 2024 · strength 0.28
  14. Vikrant Rai · 2 shared papers, 2024 · strength 0.28
  15. Divya Murthy · 2 shared papers, 2024 · strength 0.28
  16. Aneesha Dasgupta · 2 shared papers, 2024 · strength 0.28
  17. Robert Powers · 2 shared papers, 2024 · strength 0.28
  18. Teklab Gebregiworgis · 2 shared papers, 2024 · strength 0.28
  19. Nina V. Chaika · 2 shared papers, 2024 · strength 0.28
  20. Scott E. Mulder · 2 shared papers, 2024 · strength 0.28
  21. Joshua J. Souchek · 2 shared papers, 2024 · strength 0.28
  22. Sai Sundeep Kollala · 2 shared papers, 2024 · strength 0.28
  23. Ryan J. King · 2 shared papers, 2024 · strength 0.28
  24. Michael Anthony Hollingsworth · 2 shared papers, 2024 · strength 0.28
  25. Kathryn Elaine Wellen · 2 shared papers, 2024 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.